-
Coherus BioSciences (NASDAQ:CHRS) Receives "Buy" Rating from HC Wainwright
Source: Buzz FX / 12 Mar 2025 07:36:16 America/Chicago
Coherus BioSciences (NASDAQ:CHRS) Receives "Buy" Rating from HC Wainwright Written by MarketBeat March 12, 2025 Share Link copied to clipboard. Remove Ads Coherus BioSciences ( NASDAQ:CHRS - Get Free Report ) 's stock had its "buy" rating r
Read more...